vs

Side-by-side financial comparison of Immunocore Holdings plc (IMCR) and PDF SOLUTIONS INC (PDFS). Click either name above to swap in a different company.

Immunocore Holdings plc is the larger business by last-quarter revenue ($104.5M vs $62.4M, roughly 1.7× PDF SOLUTIONS INC). On growth, PDF SOLUTIONS INC posted the faster year-over-year revenue change (24.6% vs 24.3%). PDF SOLUTIONS INC produced more free cash flow last quarter ($7.5M vs $-35.5M). Over the past eight quarters, PDF SOLUTIONS INC's revenue compounded faster (22.9% CAGR vs 21.7%).

Immunocore is a global commercial-stage biotechnology company, based in Oxfordshire, which researches and develops biological drugs using soluble T-cell receptor technology.

PDF Solutions, Inc. is an American multinational software and engineering services company based in Santa Clara, California. The company is listed in the Nasdaq stock exchange under the ticker symbol PDFS.

IMCR vs PDFS — Head-to-Head

Bigger by revenue
IMCR
IMCR
1.7× larger
IMCR
$104.5M
$62.4M
PDFS
Growing faster (revenue YoY)
PDFS
PDFS
+0.3% gap
PDFS
24.6%
24.3%
IMCR
More free cash flow
PDFS
PDFS
$43.1M more FCF
PDFS
$7.5M
$-35.5M
IMCR
Faster 2-yr revenue CAGR
PDFS
PDFS
Annualised
PDFS
22.9%
21.7%
IMCR

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
IMCR
IMCR
PDFS
PDFS
Revenue
$104.5M
$62.4M
Net Profit
$-48.0K
Gross Margin
97.4%
72.9%
Operating Margin
-18.8%
5.5%
Net Margin
-0.1%
Revenue YoY
24.3%
24.6%
Net Profit YoY
-108.9%
EPS (diluted)
$-0.61
$0.00

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IMCR
IMCR
PDFS
PDFS
Q4 25
$104.5M
$62.4M
Q3 25
$103.7M
$57.1M
Q2 25
$98.0M
$51.7M
Q1 25
$93.9M
$47.8M
Q4 24
$84.1M
$50.1M
Q3 24
$80.2M
$46.4M
Q2 24
$75.4M
$41.7M
Q1 24
$70.5M
$41.3M
Net Profit
IMCR
IMCR
PDFS
PDFS
Q4 25
$-48.0K
Q3 25
$-177.0K
$1.3M
Q2 25
$-10.3M
$1.1M
Q1 25
$5.0M
$-3.0M
Q4 24
$539.0K
Q3 24
$8.7M
$2.2M
Q2 24
$-11.6M
$1.7M
Q1 24
$-24.4M
$-393.0K
Gross Margin
IMCR
IMCR
PDFS
PDFS
Q4 25
97.4%
72.9%
Q3 25
99.5%
72.3%
Q2 25
98.9%
71.2%
Q1 25
99.1%
72.9%
Q4 24
99.6%
68.3%
Q3 24
99.4%
73.1%
Q2 24
97.7%
70.6%
Q1 24
99.7%
67.3%
Operating Margin
IMCR
IMCR
PDFS
PDFS
Q4 25
-18.8%
5.5%
Q3 25
-6.9%
8.5%
Q2 25
-15.2%
2.2%
Q1 25
-3.9%
-7.4%
Q4 24
-23.1%
1.0%
Q3 24
-10.6%
4.6%
Q2 24
-21.2%
0.6%
Q1 24
-37.6%
-4.7%
Net Margin
IMCR
IMCR
PDFS
PDFS
Q4 25
-0.1%
Q3 25
-0.2%
2.3%
Q2 25
-10.5%
2.2%
Q1 25
5.4%
-6.3%
Q4 24
1.1%
Q3 24
10.9%
4.8%
Q2 24
-15.4%
4.1%
Q1 24
-34.7%
-1.0%
EPS (diluted)
IMCR
IMCR
PDFS
PDFS
Q4 25
$-0.61
$0.00
Q3 25
$0.00
$0.03
Q2 25
$-0.20
$0.03
Q1 25
$0.10
$-0.08
Q4 24
$-0.47
$0.01
Q3 24
$0.17
$0.06
Q2 24
$-0.23
$0.04
Q1 24
$-0.49
$-0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IMCR
IMCR
PDFS
PDFS
Cash + ST InvestmentsLiquidity on hand
$864.2M
$42.2M
Total DebtLower is stronger
$67.0M
Stockholders' EquityBook value
$381.0M
$271.0M
Total Assets
$1.1B
$418.7M
Debt / EquityLower = less leverage
0.25×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IMCR
IMCR
PDFS
PDFS
Q4 25
$864.2M
$42.2M
Q3 25
$892.4M
$35.9M
Q2 25
$882.8M
$40.4M
Q1 25
$837.0M
$54.1M
Q4 24
$820.4M
$114.9M
Q3 24
$901.3M
$120.2M
Q2 24
$859.6M
$117.9M
Q1 24
$832.8M
$122.9M
Total Debt
IMCR
IMCR
PDFS
PDFS
Q4 25
$67.0M
Q3 25
$67.6M
Q2 25
$68.1M
Q1 25
$68.7M
Q4 24
Q3 24
$438.7M
Q2 24
$452.5M
Q1 24
$452.5M
Stockholders' Equity
IMCR
IMCR
PDFS
PDFS
Q4 25
$381.0M
$271.0M
Q3 25
$396.6M
$264.4M
Q2 25
$388.5M
$257.5M
Q1 25
$378.5M
$249.0M
Q4 24
$360.7M
$246.0M
Q3 24
$377.8M
$240.5M
Q2 24
$359.1M
$232.2M
Q1 24
$359.5M
$225.4M
Total Assets
IMCR
IMCR
PDFS
PDFS
Q4 25
$1.1B
$418.7M
Q3 25
$1.1B
$406.4M
Q2 25
$1.1B
$391.1M
Q1 25
$1.0B
$390.0M
Q4 24
$1.0B
$315.3M
Q3 24
$1.1B
$307.4M
Q2 24
$1.0B
$298.0M
Q1 24
$994.0M
$286.8M
Debt / Equity
IMCR
IMCR
PDFS
PDFS
Q4 25
0.25×
Q3 25
0.26×
Q2 25
0.26×
Q1 25
0.28×
Q4 24
Q3 24
1.16×
Q2 24
1.26×
Q1 24
1.26×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IMCR
IMCR
PDFS
PDFS
Operating Cash FlowLast quarter
$-32.7M
$17.3M
Free Cash FlowOCF − Capex
$-35.5M
$7.5M
FCF MarginFCF / Revenue
-34.0%
12.1%
Capex IntensityCapex / Revenue
2.8%
15.7%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-15.1M
$-8.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IMCR
IMCR
PDFS
PDFS
Q4 25
$-32.7M
$17.3M
Q3 25
$-4.5M
$3.3M
Q2 25
$26.0M
$-5.2M
Q1 25
$435.0K
$8.6M
Q4 24
$-14.0M
$1.6M
Q3 24
$21.1M
$9.3M
Q2 24
$23.5M
$684.0K
Q1 24
$-4.6M
$-1.9M
Free Cash Flow
IMCR
IMCR
PDFS
PDFS
Q4 25
$-35.5M
$7.5M
Q3 25
$-5.2M
$-2.9M
Q2 25
$25.6M
$-13.8M
Q1 25
$137.0K
$535.0K
Q4 24
$-17.5M
$-4.0M
Q3 24
$20.3M
$5.1M
Q2 24
$23.1M
$-4.6M
Q1 24
$-5.0M
$-3.9M
FCF Margin
IMCR
IMCR
PDFS
PDFS
Q4 25
-34.0%
12.1%
Q3 25
-5.0%
-5.1%
Q2 25
26.1%
-26.6%
Q1 25
0.1%
1.1%
Q4 24
-20.9%
-8.0%
Q3 24
25.3%
11.0%
Q2 24
30.7%
-11.1%
Q1 24
-7.1%
-9.4%
Capex Intensity
IMCR
IMCR
PDFS
PDFS
Q4 25
2.8%
15.7%
Q3 25
0.7%
10.8%
Q2 25
0.4%
16.5%
Q1 25
0.3%
17.0%
Q4 24
4.3%
11.3%
Q3 24
1.0%
9.0%
Q2 24
0.4%
12.8%
Q1 24
0.6%
4.9%
Cash Conversion
IMCR
IMCR
PDFS
PDFS
Q4 25
Q3 25
2.54×
Q2 25
-4.55×
Q1 25
0.09×
Q4 24
2.98×
Q3 24
2.42×
4.20×
Q2 24
0.40×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

IMCR
IMCR

Segment breakdown not available.

PDFS
PDFS

Volumebased$38.0M61%
Other$24.4M39%

Related Comparisons